期刊文献+

系统性红斑狼疮患者骨髓间质干细胞对B淋巴细胞免疫抑制作用的初步研究 被引量:5

Immunosuppressive effects of bone marrow-derived mesenchymal stem cells on B lymphocytes in systemic lupus erythematosus patients
原文传递
导出
摘要 目的:探讨系统性红斑狼疮(SLE)患者骨髓间质干细胞(MSCs)体外对B淋巴细胞的免疫调节作用是否存在异常。方法:采用直接贴壁法分离培养正常人及SLE患者MSCs。免疫磁珠法分选正常人外周血B淋巴细胞,与MSCs共培养,流式细胞术检测B细胞凋亡及表面标志表达,3H掺入法检测B细胞增殖,酶联免疫吸附法(ELISA)检测培养上清中免疫球蛋白IgG、IgM和IgA水平。结果:①B细胞+正常MSCs共培养组B细胞增殖(4307±308)cpm较单纯B细胞培养组(7059±346)cpm降低(P〈0.05);②B细胞+正常MSCs共培养组B细胞凋亡率(14±7)%低于单纯B细胞培养组(25±8)%(P〈0.05);③B细胞+正常MSCs共培养组B细胞表面CD86表达率(53±5)%较单纯B细胞培养组(66±10)%低(P〈0.05);④与MSCs共培养后,B细胞分泌免疫球蛋白IgG、IgM和IgA较单纯B细胞培养显著减少(P〈0.05);⑤B细胞+狼疮MSCs共培养组与B细胞+正常MSCs共培养组比较,B细胞增殖、凋亡、CD86表达和Ig分泌两组间差异无统计学意义。结论:MSCs在体外对B细胞有抑制作用,SLE患者骨髓MSCs与正常MSCs相比,对B细胞的表面刺激分子表达、增殖、Ig分泌有相似的抑制作用。 Objective To investigate the immunoregulatory effects of bone marrow derived mesenchymal stem cells (MSCs) on B lymphocytes in systemic lupus erythematosus (SLE). Methods Human bone marrow MSCs were isolated from SLE patients and normal controls and cultured ex vivo. B lymphocytes were purified from normal peripheral blood mononuclear cells by using CD19 microbeads. Purified B cells were cocultured in 96-well flat-bottom plates with MSCs. B cell apoptosis and surface markers were analyzed by flow cytometry. B cell proliferation was assessed by [^3H]-thymidine incorporation. ELISA was used to measure supernatant levels of IgG, IgM and IgA. Results ①B cell proliferation in normal MSCs coculture group (4307± 308) cpm was significantly inhibited compared to simple B cell group (7059±346) cpm (P〈0.05);②B cell apoptotic percentage in normal MSCs cocuhure group (14±7)% was lower than in B cell group (25±8)% (P〈 0.05); ③The percentage of CD86 molecule expression on B cells in normal MSCs coculture group (53±5)% was lower than that in simple B cell group (66±10)% (P〈0.05);④The levels of IgG, IgM and IgA secreted by B cell decreased when cocuhured with MSCs (P〈0.05); ⑤There were no significant differences of B cell proliferation, apoptosis, CD86 expression and immunoglobulin production regulated by MSCs from lupus patients and normal controls. Conclusion MSCs show an inhibitory effect on B cells. Both MSCs from SLE patients and normal MSCs have similar patterns in B cell proliferation, activation and immunoglobulin production.
出处 《中华风湿病学杂志》 CAS CSCD 2007年第9期524-527,共4页 Chinese Journal of Rheumatology
基金 教育部高等学校博士点基金资助项目(20050315001) 江苏省135重点人才基金资助项目(RC2002003) 江苏省自然科学基金资助项目(BK2006007)
关键词 间质干细胞 B淋巴细胞 红斑狼疮 系统性 细胞增殖 免疫球蛋白 Mesenchymal stem cells B-lymphocytes Lupus erythematosus, systemic Cell proliferation Immunoglobulin
  • 相关文献

参考文献9

  • 1Di M, Carlo C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002, 99: 3838-3843.
  • 2Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dentritic cells.Blood, 2005, 105: 4120-4126.
  • 3El-Badri NS, Pascual C, Ferrari A, et al. Abnormalities of stromal cells in autoimmune systemic lupus murine model. Blood, 2004, 104: 364A.
  • 4李慧,梁军,侯亚义,范乐明,孙凌云.NZBWF1/J鼠骨髓间充质干细胞对T淋巴细胞亚群平衡的免疫调节[J].中华风湿病学杂志,2006,10(8):457-461. 被引量:15
  • 5张华勇,冯学兵,孙凌云.系统性红斑狼疮患者骨髓间质干细胞生物学特性及对造血支持的研究[J].中华风湿病学杂志,2006,10(6):331-334. 被引量:13
  • 6Bemasconi NL, Onai N, I.,anzavecchia A. A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood, 2003, 101: 4500-4504.
  • 7Panagiota A, Sonia A, Angelos D, et al. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells, 2006, 24: 74-85.
  • 8Anna C, Federica B, Elisa F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood, 2006, 107: 367-372.
  • 9Spronk E, Horst G, Limburg P, et al. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE). Clin Exp Immunol, 1996, 104: 446-453.

二级参考文献24

  • 1霍建忠,陈峥嵘,蒋淳,郭常安,朱列伟,高飞.转化生长因子-β_1基因修饰骨髓间充质干细胞复合壳聚糖修复兔关节软骨缺损[J].中华风湿病学杂志,2005,9(7):393-396. 被引量:8
  • 2孙凌云,顾宁琰,侯亚义,范乐明.系统性红斑狼疮骨髓间质干细胞的初步研究[J].中华风湿病学杂志,2005,9(10):586-589. 被引量:7
  • 3Friedenstein AJ,Petrakova KV,Kurolesova AL,et al.Heterotopic transplants of bone marrow:analysis of precursor cells for osteogenic and hematopoietic tissues.Transplantation,1968,6:230-247.
  • 4Haynesworth SE,Baber MA,Caplan AL.Cell surface antigens on human marrow-derived mesenchymal stem cells are detected by monoclonal antibodies.Bone,1992,13:69-80.
  • 5Koc ON,Gerson SL,Cooper BW,et al.Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.J Clin Oncol,2000,18:307-316.
  • 6Noort WA,Kruisselbrink AB,in't Anker PS,et al.Mesenchymal stem cells promote engraftment of human umbilical cord bloodderived CD34+ cells in NOD/SCID mice.Exp Hematol,2002,30:870-878.
  • 7Le Blanc K,Ringden O.Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.Biol Blood Marrow Transplant,2005,11:321-334.
  • 8Hochberg MC.Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum,1997,40:1725.
  • 9Papadaki HA,Boumpas DT,Gibson FM,et al.Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus.Br J Haematol,2001,115:167-174.
  • 10Pittenger MF, Mackay AM, Beck SC, et al, Muhilineage potential of adult human mesenchymal stem cells. Science, 1999, 284:143-147.

共引文献21

同被引文献46

  • 1李慧,孙凌云.间质干细胞的免疫调节及免疫治疗作用研究进展[J].中华医学杂志,2006,86(7):501-503. 被引量:15
  • 2段京明,李茂胜,李志军,李季青,谢长好.抗SmD1抗体测定对系统性红斑狼疮的诊断意义[J].蚌埠医学院学报,2006,31(3):255-257. 被引量:6
  • 3Pittinger M, Mackay A, Beck S, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999,284 : 143- 147.
  • 4Li Y,Hisha H, lnaba M, et al. Evidence for migration of donor bone marrow stromal cells into recipient thymus after bone marrow transplantation plus bone grafts: a role of stromal cells in positive selection. Exp Hematol,2000,28:950-960.
  • 5Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol,2000,28:875-884.
  • 6Le Blanc K, Tammik L, Zetterberg E,et al. HLA-expression and immunologic properties of undifferentiated and differentiated mesenchymal stem cells. Exp Hematol,2003,31:890.
  • 7Tse WT, Pendleton JD, Beyer WM, et al. Suppression of allogeneic T-cell proliferation bv human marrow stromal cells: Implications in transplantation. Transplantation, 2003,75 : 389-397.
  • 8Sun LY, Zhang HY, Fen XB, et al. Abnormality of bone marrow-derived stem cell in patients with systemic lupus erythematosus.Lupus,2007,16:121-128.
  • 9Di Nicola M,Carlo-Stella C,Magni M,et al. Human bone marrow stromal cells suppress T-lymohocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002,99 : 3838- 3843.
  • 10Sun LY, Li H, Liang J, et al. The polarization of T lymphocytes modulated by mesenchymal stem cells in NZB/WF1 and BALB/C mice. Int J Mol Sci, 2007, 8:455-469.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部